Atlas Trials

Study of Neuroimaging Biomarkers of Social Cognition Deficits in Adolescents (Age 13-17) With Autism Spectrum Disorder and Effects of Gabapentin

Clinical trial NCT03589898 · COMPLETED

Trial details

NCT number
NCT03589898
Sponsor
University of Massachusetts, Worcester
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
Autism Spectrum Disorder
Start date
2017-09-14
Primary completion
2022-08-31
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.